Literature DB >> 19817593

Multicenter, hospital-based surveillance of rotavirus disease and strains among indian children aged <5 years.

Gagandeep Kang1, Rashmi Arora, Shobha D Chitambar, Jagdish Deshpande, M D Gupte, Madhuri Kulkarni, Trilok N Naik, Dipali Mukherji, S Venkatasubramaniam, Jon R Gentsch, Roger I Glass, Umesh D Parashar.   

Abstract

BACKGROUND: Current, nationally representative data on rotavirus disease burden and rotavirus strains in India are needed to understand the potential health benefits of rotavirus vaccination.
METHODS: The Indian Rotavirus Strain Surveillance Network was established with 4 laboratories and 10 hospitals in 7 different regions of India. At each hospital, children aged <5 years who presented with acute gastroenteritis and required hospitalization with rehydration for at least 6 h were enrolled. A fecal specimen was obtained and was tested for rotavirus with use of a commercial enzyme immunoassay, and strains were characterized using reverse-transcription polymerase chain reaction.
RESULTS: From December 2005 through November 2007, rotavirus was found in approximately 39% of 4243 enrolled patients. Rotavirus was markedly seasonal in northern temperate locations but was less seasonal in southern locations with a tropical climate. Rotavirus detection rates were greatest among children aged 6-23 months, and 13.3% of rotavirus infections involved children aged <6 months. The most common types of strains were G2P[4] (25.7% of strains), G1P[8] (22.1%), and G9P[8] (8.5%); G12 strains were seen in combination with types P[4], P[6], and P[8] and together comprised 6.5% of strains.
CONCLUSIONS: These data highlight the need for development and implementation of effective prophylactic measures, such as vaccines, to prevent the large burden of rotavirus disease among Indian children.

Entities:  

Mesh:

Year:  2009        PMID: 19817593     DOI: 10.1086/605031

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Authors:  Hiten D Patel; Eric T Roberts; Dagna O Constenla
Journal:  Vaccine       Date:  2013-10-29       Impact factor: 3.641

2.  Full genomic analysis and possible origin of a porcine G12 rotavirus strain RU172.

Authors:  S Ghosh; N Kobayashi; S Nagashima; M Chawla-Sarkar; T Krishnan; B Ganesh; T N Naik
Journal:  Virus Genes       Date:  2010-02-16       Impact factor: 2.332

3.  Update on available vaccines in India: report of the APPA VU 2010: I.

Authors:  Sunil Karande
Journal:  Indian J Pediatr       Date:  2011-03-05       Impact factor: 1.967

4.  Prevalence of rotavirus infection in children below two years presenting with diarrhea.

Authors:  B M John; Amit Devgan; Barnali Mitra
Journal:  Med J Armed Forces India       Date:  2014-04-03

Review 5.  Rotavirus vaccines: update on global impact and future priorities.

Authors:  Catherine Yen; Jacqueline E Tate; Manish M Patel; Margaret M Cortese; Benjamin Lopman; Jessica Fleming; Kristen Lewis; Baoming Jiang; Jon Gentsch; Duncan Steele; Umesh D Parashar
Journal:  Hum Vaccin       Date:  2011-12-01

6.  Serological evidence of human klassevirus infection.

Authors:  Alexander L Greninger; Lori Holtz; Gagandeep Kang; Donald Ganem; David Wang; Joseph L DeRisi
Journal:  Clin Vaccine Immunol       Date:  2010-08-25

7.  Rotavirus Infection and Disease in a Multisite Birth Cohort: Results From the MAL-ED Study.

Authors:  Venkata Raghava Mohan; Ramanujam Karthikeyan; Sudhir Babji; Monica McGrath; Sanjaya Shrestha; Jasmin Shrestha; Estomih Mdumah; Caroline Amour; Amidou Samie; Emanuel Nyathi; Rashidul Haque; Shahida Qureshi; Pablo Peñataro Yori; Aldo A M Lima; Ladaporn Bodhidatta; Erling Svensen; Pascal Bessong; Tahmeed Ahmed; Jessica C Seidman; Anita K M Zaidi; Margaret N Kosek; Richard L Guerrant; Jean Gratz; James A Platts-Mills; Dennis R Lang; Michael Gottlieb; Eric R Houpt; Gagandeep Kang
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

8.  The VP8* domain of neonatal rotavirus strain G10P[11] binds to type II precursor glycans.

Authors:  Sasirekha Ramani; Nicolas W Cortes-Penfield; Liya Hu; Sue E Crawford; Rita Czako; David F Smith; Gagandeep Kang; Robert F Ramig; Jacques Le Pendu; B V Venkataram Prasad; Mary K Estes
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants.

Authors:  M R Lokeshwar; Sheila Bhave; Ashok Gupta; V K Goyal; Anuj Walia
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

10.  A significant and consistent reduction in rotavirus gastroenteritis hospitalization of children under 5 years of age, following the introduction of universal rotavirus immunization in Israel.

Authors:  Khitam Muhsen; Uri Rubenstein; Eias Kassem; Sophy Goren; Yaakov Schachter; Adi Kremer; Lester M Shulman; Moshe Ephros; Dani Cohen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.